RESOLVING THE LEDGER
RESOLVING THE LEDGER
This is not a single article. It's every outletcovering this one event, gathered in one place — read AIPROPX's summary, see where the sources line up, then open any report at its origin.
By AIPROPX Editorial Desk · Published · Updated
Everything reported about this story, gathered from 3 sources. Read the summary below, then tap any source to open that report.
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer's disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer's disease. It's the fourth such...
Summary indexed by AIPROPX from The Hill’s reporting — the full article is one click away. Open at source →
3 outlets are covering this. Resolve the ledger to read what they collectively report — the common thread, in plain terms.
Every report on this story — read the summary of each, then open any at its source. AIPROPX summarizes and links; it never reproduces the original.
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer's disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer's disease. It's the fourth such...
Read this reportThe nod follows European approval for the Elecsys pTau217 test in May.
Read this reportAn original, deterministic readout — composed only from the computed coverage facts on this page. No interpretation, no rating; figures only.
AIPROPX has consolidated 3 reports from 3 outlets into a single canonical entry on “FDA approves new blood test for Alzheimer’s disease.” The covered outlets are based across 3 regions — US, International, and Other.
The earliest report in this entry came from The Straits Times (Aug 24, 2026, 14:02 UTC); the most recent came from The Hill (Aug 24, 2026, 22:02 UTC).
Comparing the wording across sources, 2 named entities are referenced by multiple outlets and the phrase recurring most across the coverage is “blood test”.
3 statements are carried by only one outlet within this set and are not echoed by the others.
Every figure above is a direct count of real published articles. AIPROPX indexes and compares the original reporting — it never rewrites, rates, or editorializes — and each publisher’s full article is always one click away.
Generated by AIPROPX from the source counts above. AIPROPX indexes and resolves coverage; the original publishers are credited and linked at origin in every report.
Coverage from 3 independent outlets across 3 regions — each view opens on its own page.
AIPROPX — “FDA approves new blood test for Alzheimer’s disease” · https://www.aipropx.com/story/4431f249452315b53f9a064ac18bd109
Other events being covered across multiple sources right now.
Supreme Court Allows Trump Plan to Restrict Mail-In Voting, for Now
17 outlets5 ways Iran's economy is wilting under Trump's pressure
10 outletsTrump administration to revoke visas of foreigners seeking asylum in US, officials say
7 outletsLindsay Clancy trial judge denies mistrial request, reprimands prosecution
4 outletsAmerican Red Cross partners with Hello Kitty to encourage blood donations
3 outletsAfter handcuff footage, ECB takes big call on Carse before Pakistan 2nd Test